InVivium Capital — 2023 Investments

1 investments dated 2023 · listed companies and verified rows first · show all

Alto Neurosciencealtoneuroscience.com in 𝕏NYSE: ANRONov 2023

Alto Neuroscience is a clinical-stage biopharmaceutical company developing biology-driven medicines for neuropsychiatric conditions, using measurements of brain biology to predict clinical response and identify patients likely to benefit from its drug candidates.

BiotechDigital HealthMental HealthMountain View, US

Amit Etkin(Founder)inAdam Savitz(Executive Officer)inMichael Hanley(Executive Officer)Nicholas Smith(Chief Financial Officer and Chief Business Officer)inAaron Weaver(Director)Po Yu (Jeff) Chen(Director)

Board seatMichael Liang· per SEC Form D

Co-investorsAble Partners Alpha Wave Global Gaingels K2 HealthVentures Korify Capital Mana Ventures +12 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.